v2.4.0.8

Summary of Segment Net Revenues, Segment Operating Income Loss and Reconciliation of Segment Income to Consolidated Income from Continuing Operations Before Income Taxes (Detail) (USD $) In Thousands, unless otherwise specified | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues | $ 3,063,209 | $ 2,999,586 | $ 2,871,673 | $ 2,829,582 | $ 2,477,853 | $ 1,945,888 | $ 1,913,006 | $ 1,849,533 | $ 8,307,195 |  | $ 7,351,902 |  | $ 6,470,540 |
Less: Provision for uncollectible accounts |  |  |  |  |  |  |  |  | (293,546) |  | (235,218) |  | (190,234) |
Total net operating revenues |  |  |  |  |  |  |  |  | 11,764,050 |  | 8,186,280 |  | 6,731,806 |
Net patient service revenues |  |  |  |  |  |  |  |  | 8,013,649 |  | 7,116,684 |  | 6,280,306 |
Other revenues |  |  |  |  |  |  |  |  | 763,086 |  | 588,260 |  | 406,367 |
Contingent earn-out obligation adjustment |  |  |  |  |  |  |  |  | 56,977 |  |  |  |  |
Corporate support costs |  |  |  |  |  |  |  |  | (65,041) | [1] | (52,457) | [1] | (47,051) | [1]
Transaction expenses |  |  |  |  |  |  |  |  |  |  | (30,753) |  |  |
Operating income | 484,179 | 377,074 | 522,020 | 166,861 | 388,056 | 340,885 | 247,261 | 320,882 | 1,550,134 |  | 1,297,084 |  | 1,154,713 |
Debt expense |  |  |  |  |  |  |  |  | (429,943) |  | (288,554) |  | (241,090) |
Debt refinancing and redemption charges |  |  |  |  |  |  |  |  |  |  | (10,963) |  |  |
Other income |  |  |  |  |  |  |  |  | 4,787 |  | 3,737 |  | 2,982 |
Consolidated income from continuing operations before income taxes | 380,020 | 270,766 | 412,550 | 61,642 | 282,162 | 271,210 | 187,392 | 260,540 | 1,124,978 |  | 1,001,304 |  | 916,605 |
U.S. dialysis and related lab services |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | 8,032,772 |  | 7,316,818 |  | 6,473,952 |
Less: Provision for uncollectible accounts |  |  |  |  |  |  |  |  | (281,146) |  | (233,580) |  | (190,234) |
Net patient service revenues |  |  |  |  |  |  |  |  | 7,751,626 |  | 7,083,238 |  | 6,283,718 |
Other revenues |  |  |  |  |  |  |  |  | 12,600 | [2] | 11,447 | [2] | 11,019 | [2]
HealthCare Partners (HCP) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | 2,920,214 |  | 419,431 |  |  |
Net patient service revenues |  |  |  |  |  |  |  |  | 220,251 |  | 34,407 |  |  |
Other revenues |  |  |  |  |  |  |  |  | 55,723 |  | 23,552 |  |  |
Other-ancillary services and strategic initiatives |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | 67,351 |  | 61,906 |  | 45,133 |
Net patient service revenues |  |  |  |  |  |  |  |  | 75,852 |  | 16,824 |  | 7,730 |
Other revenues |  |  |  |  |  |  |  |  | 694,763 |  | 553,261 |  | 395,347 |
Operating Segments |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total net operating revenues |  |  |  |  |  |  |  |  | 11,812,296 |  | 8,214,547 |  | 6,748,743 |
Operating income |  |  |  |  |  |  |  |  | 1,558,198 | [3] | 1,380,294 | [3] | 1,201,764 | [3]
Operating Segments | U.S. dialysis and related lab services |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | 7,998,692 |  | 7,299,032 |  | 6,462,811 |
Total net operating revenues |  |  |  |  |  |  |  |  | 7,764,226 |  | 7,094,685 |  | 6,294,737 |
Operating income |  |  |  |  |  |  |  |  | 1,211,540 | [3] | 1,378,241 | [3] | 1,235,869 | [3]
Operating Segments | HealthCare Partners (HCP) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | 2,919,964 |  | 419,431 |  |  |
Total net operating revenues |  |  |  |  |  |  |  |  | 3,196,188 |  | 477,390 |  |  |
Operating income |  |  |  |  |  |  |  |  | 385,253 | [3] | 66,930 | [3] |  |
Operating Segments | Other-ancillary services and strategic initiatives |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total net operating revenues |  |  |  |  |  |  |  |  | 851,882 |  | 642,472 |  | 454,006 |
Operating income |  |  |  |  |  |  |  |  | (38,595) | [3] | (64,877) | [3] | (34,105) | [3]
Intersegment Elimination |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total net operating revenues |  |  |  |  |  |  |  |  | (48,246) |  | (28,267) |  | (16,937) |
Intersegment Elimination | U.S. dialysis and related lab services |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | (34,080) |  | (17,786) |  | (11,141) |
Intersegment Elimination | HealthCare Partners (HCP) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Patient service operating revenues |  |  |  |  |  |  |  |  | 250 |  |  |  |  |
Intersegment Elimination | Other-ancillary services and strategic initiatives |  |  |  |  |  |  |  |  |  |  |  |  |  |
Segment Reporting Information [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total net operating revenues |  |  |  |  |  |  |  |  | $ (13,916) |  | $ (10,481) |  | $ (5,796) |
[1] | Corporate support costs also include $7,721 of an adjustment to reduce a tax asset associated with the HCP acquisition escrow provisions
[2] | Includes management fees for providing management and administrative services to dialysis centers in which the Company owns a minority equity investment or which are wholly-owned by third parties.
[3] | Certain costs previously reported in the ancillary services and strategic initiatives have been reclassified to U.S. dialysis and related lab services to conform to the current year presentation.

X
- Definition Represents interest and the amortization of deferred financings costs incurred in the period on debt arrangements that were charged against earnings. + References No definition available. + Details
Name: | dva_DebtExpense
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of debt refinancing charges + References No definition available. + Details
Name: | dva_DebtRefinancingCharge
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the current period expense charged against patient service revenue, the offset which is generally to the allowance for doubtful accounts for the purpose of reducing patient service receivables, to an amount that approximates their net realizable value (the amount expected to be collected). + References No definition available. + Details
Name: | dva_ProvisionForDoubtfulAccountsOnPatientServiceRevenue
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Segment Reporting Information Acquisitions Related Transaction expenses + References No definition available. + Details
Name: | dva_SegmentReportingInformationAcquisitionsRelatedTransactionExpenses
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs. + References No definition available. + Details
Name: | dva_SegmentReportingInformationCorporateExpenses
Namespace Prefix: | dva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of (increase) decrease in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of revenue recognized that is not otherwise disclosed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_HealthCareOrganizationOtherRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenue recognized for providing services to patients, net of provisions for contractual allowances and discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=9156363&loc=d3e8184-115640 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=9156363&loc=SL9156442-115640 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=25502053&loc=SL9156464-115641 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=9156363&loc=d3e8195-115640 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 4 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=9156363&loc=SL9156442-115640 + Details
Name: | us-gaap_HealthCareOrganizationPatientServiceRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of patient service revenue, net of contractual allowances and discounts, less the related provision for bad debts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 954 -SubTopic 605 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=9156363&loc=SL9156442-115640 + Details
Name: | us-gaap_HealthCareOrganizationPatientServiceRevenueLessProvisionForBadDebts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of revenues recognized by the entity from providing services to in-patients, outpatients, residents in facilities owned or operated by the entity, from insurance premiums, or from goods provided or services performed. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_HealthCareOrganizationRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 9 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherNonoperatingIncomeExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration